Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M186,514Revenue $M51,584Net Margin (%)42.7Z-Score2.6
Enterprise Value $M189,932EPS $3.2Operating Margin %30.5F-Score5
P/E(ttm))9.5Cash Flow Per Share $3.5Pre-tax Margin (%)30.5Higher ROA y-yY
Price/Book2.410-y EBITDA Growth Rate %3.2Quick Ratio2.1Cash flow > EarningsN
Price/Sales3.95-y EBITDA Growth Rate %8.5Current Ratio2.3Lower Leverage y-yY
Price/Cash Flow7.2y-y EBITDA Growth Rate %14.1ROA % (ttm)12.8Higher Current Ratio y-yN
Dividend Yield %3.4Insider Buy (3m)0ROE % (ttm)28.8Less Shares Outstanding y-yY
Payout Ratio %66.0Shares Outstanding M6,379ROI % (ttm)21.6Gross Margin Increase y-yN

Gurus Latest Trades with PFE

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactup Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PFEJoel Greenblatt 2013-06-30 Reduce-0.05%$27.23 - $31.08
($29.12)
$ 29.260%Reduce -66.69%18,092
PFEGeorge Soros 2013-06-30 Sold Out -0.06%$27.23 - $31.08
($29.12)
$ 29.260%Sold Out0
PFEJean-Marie Eveillard 2013-06-30 Reduce-0.34%$27.23 - $31.08
($29.12)
$ 29.260%Reduce -54.03%3,017,033
PFEVanguard Health Care Fund 2013-06-30 Reduce-0.87%$27.23 - $31.08
($29.12)
$ 29.260%Reduce -24.15%23,968,323
PFEMichael Price 2013-06-30 Reduce-0.91%$27.23 - $31.08
($29.12)
$ 29.260%Reduce -41.38%347,100
PFEYacktman Focused Fund 2013-06-30 Sold Out -2.21%$27.23 - $31.08
($29.12)
$ 29.260%Sold Out0
PFEDonald Yacktman 2013-06-30 Reduce-2.39%$27.23 - $31.08
($29.12)
$ 29.260%Reduce -99.74%41,700
PFEYacktman Fund 2013-06-30 Sold Out -2.65%$27.23 - $31.08
($29.12)
$ 29.260%Sold Out0
PFEJean-Marie Eveillard 2013-03-31 Add0.23%$25.079 - $28.86
($27.3)
$ 29.267%Add 57.8%6,562,712
PFERay Dalio 2013-03-31 Reduce-0.01%$25.079 - $28.86
($27.3)
$ 29.267%Reduce -26.27%57,808
PFERay Dalio 2012-12-31 Add0.01%$23.66 - $26.04
($25.01)
$ 29.2617%Add 73.45%78,400
PFEDavid Dreman 2012-12-31 Reduce-0.23%$23.66 - $26.04
($25.01)
$ 29.2617%Reduce -77.06%110,998
PFERonald Muhlenkamp 2012-12-31 Reduce-1.7%$23.66 - $26.04
($25.01)
$ 29.2617%Reduce -89.46%37,624
PFEJoel Greenblatt 2012-09-30 Add0.02%$22.34 - $24.95
($23.74)
$ 29.2623%Add 40.57%44,666
PFERay Dalio 2012-09-30 Reduce-0.02%$22.34 - $24.95
($23.74)
$ 29.2623%Reduce -54.16%45,200
PFEGeorge Soros 2012-09-30 Reduce-0.12%$22.34 - $24.95
($23.74)
$ 29.2623%Reduce -69.36%165,000
PFEDavid Dreman 2012-09-30 Reduce-0.13%$22.34 - $24.95
($23.74)
$ 29.2623%Reduce -34.04%483,957
PFEJohn Hussman 2012-09-30 Sold Out -0.43%$22.34 - $24.95
($23.74)
$ 29.2623%Sold Out0
PFERay Dalio 2012-06-30 Buy 0.03%$21.42 - $23.21
($22.39)
$ 29.2631%New holding, 98600 sh.98,600
PFERichard Perry 2012-06-30 Sold Out -0.03%$21.42 - $23.21
($22.39)
$ 29.2631%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PFE is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
PFE Vanguard Health Care Fund 2014-06-3014,934,0220.231.2+105.23%
PFE John Hussman 2014-03-3117,00000.04New Buy
PFE Joel Greenblatt 2014-03-311,014,8080.020.49+356.54%
PFE David Dreman 2014-03-3111,85100.03+16.61%
PFE Ray Dalio 2014-03-31112,10800.03+1.54%
PFE Ruane Cunniff 2014-03-3111,02200
PFE Prem Watsa 2014-03-31235,00000.53
PFE Michael Price 2014-03-31347,1000.011.4
PFE Charles Brandes 2014-03-315,743,7110.092.3-0.41%
PFE Mario Gabelli 2014-03-311,165,5740.020.2-1.53%
PFE Dodge & Cox 2014-03-3164,121,0171.012.1-1.79%
PFE James Barrow 2014-03-3159,895,5710.942.8-2.55%
PFE John Keeley 2014-03-3195,89300.05-8.21%
PFE Ronald Muhlenkamp 2014-03-3141,16900.23-8.77%
PFE Jean-Marie Eveillard 2014-03-317,866,4730.120.67-22.77%
Premium Most recent portfolio changes are included for Premium Members only!


PFE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
OLSON LAURIE JExecutive Vice President 2014-06-12Sell36,275$29.53-1.05view
Germano Geno JGroup President 2014-06-02Sell30,000$29.68-1.55view
YOUNG JOHN DGroup President 2014-03-17Sell9,000$31.38-6.88view
PFIZER INC10% Owner 2014-03-12Buy272,727$11165.64view
CANGIALOSI LORETTA VSr. Vice President, Controller 2014-03-04Sell102,943$32.05-8.83view
Dolsten MikaelPresident R&D 2014-03-04Sell35,789$32.58-10.31view
SUSMAN SALLYExecutive Vice President 2014-03-04Sell67,585$32.59-10.34view
PFIZER INC10% Owner 2014-02-04Buy227,261$8265.25view
DAMELIO FRANK AExecutive Vice President 2014-01-13Sell131,810$30.82-5.19view
DAMELIO FRANK AExecutive Vice President 2014-01-13Sell28,190$30.86-5.31view

Press Releases about PFE :

Quarterly/Annual Reports about PFE:

    News about PFE:

    Articles On GuruFocus.com
    Is Ken Fisher a Dividend Growth Investor? Jul 27 2014 
    Diamond Hill Capital Comments on Pfizer Inc Jul 25 2014 
    Dodge & Cox Second Quarter 2014 Commentary Jul 23 2014 
    Pfizer: A Fairly Valued Stock Jul 23 2014 
    Although This Hedge Fund Changed Stocks in Three of Them Bet More Jul 21 2014 
    Guru Favorites Top GuruFocus Dividend Growers of the Weeks Jul 01 2014 
    Can Pfizer Make Up Its Loss? May 09 2014 
    Auxier Asset Management's Auxier Report - First Quarter 2014 May 06 2014 
    Will Pfizer’s Q1 2014 Earnings Beat the Street on May 5, 2014? May 05 2014 
    Wrong Marketing Lesson by Big Pharma May 03 2014 


    More From Other Websites
    Top defensive picks in offensive sectors Jul 30 2014
    Pfizer buying two Baxter vaccines for $635M Jul 30 2014
    Pfizer buying two Baxter vaccines for $635M Jul 30 2014
    10:34 am Pfizer: InnoPharma announces launch of Olanzapine for injection, 10mg/vial in Canada Jul 30 2014
    InnoPharma Announces Launch of Olanzapine for Injection, 10mg/vial in Canada Jul 30 2014
    Why Pfizer (PFE) Stock Is Down Today Jul 30 2014
    Pfizer to buy Baxter's vaccines unit for $635 mln Jul 30 2014
    Pfizer to buy Baxter’s vaccines for $635 million Jul 30 2014
    [$$] Pfizer To Buy Baxter's Vaccines Jul 30 2014
    Pfizer Enters Into Agreement to Acquire Baxter’s Portfolio of Marketed Vaccines Jul 30 2014
    Pfizer Enters Into Agreement to Acquire Baxter’s Portfolio of Marketed Vaccines Jul 30 2014
    [$$] Pfizer Still Looking to Buy Jul 29 2014
    Pfizer leaves investors guessing on intentions for Astra Jul 29 2014
    Stocks close lower as global tensions take a toll Jul 29 2014
    Merck, Pfizer Ramping R&D After Q2 Earnings Beat Jul 29 2014
    Pfizer leaves investors guessing on intentions for Astra Jul 29 2014
    Pfizer leaves investors guessing on intentions for Astra Jul 29 2014
    Pfizer leaves investors guessing on intentions for Astra Jul 29 2014
    Pfizer Traders Fickle on Stock After Q2 Beat Jul 29 2014
    Pfizer CEO: Shareholders Happy with Price Discipline on AstraZeneca Jul 29 2014

    Add Notes, Comments or Ask Questions

    User Comments

    SEENSCO
    ReplySEENSCO - 1 month ago
    PFE is trading at the low end of our short-term valuation range ($29-$36) and significantly below our Fair Value estimate of $42.41.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide